Substance Use & Drug Information News Briefs

March 27, 2025

CEU Course of the Week:

Understanding and Treating Stimulant Use Disorders



THE IMPENDING AMPHETAMINE MISUSE CRISIS


This week we take a look at a potentially serious trend: The misuse of amphetamines within America. According to a recent paper in JAMA Psychiatry, more than a quarter of adults 18-64 years old who are prescribed amphetamines (primarily for ADD) misuse them, and 9% have a (prescription) Stimulant Use Disorder. In the study, methylphenidate (Ritalin) has a slightly lower misuse potential.


First synthesized in 1887, amphetamines were freely prescribed in the 1960s and early 70s,for weight reduction, depression and fatigue. Drugs such as Dexedrine (dextroamphetamine), Dexamyl, Eskatrol and Benzedrine (amphetamine sulfate) were known as debs, dexies, brown-and-clears, green-and-clears, Christmas trees and, generically, speed. From the very beginning of therapeutic amphetamine use, misuse occurred, and a 1932 medical text describes amphetamine psychosis. 


In this edition of the newsletter, we feature three articles/papers that describe the misuse of amphetamines by those who have had the drug prescribed for them. The first is from the JAMA Psychiatry, the second from Psychology Today, and the third from Becker's Behavioral Health. They describe a current environment in which increasing amphetamine misuse is likely. All of the factors of this environment are similar to those that were in place just prior to the amphetamine epidemic of the 1960s.These factors include a growing number of adults and youth diagnosed with Attention Deficit Disorder (hyperactive, distracted or mixed) and increased amphetamine production (which results in increased diversion to the nonmedical community).

Sources: 

Gold, MS. The New Amphetamine Crisis. Psychology Today, March 25, 2025.

Han B, Jones CM, Volkow ND, et al. Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years. JAMA Psychiatry. Published online March 19, 2025. doi:10.1001/jamapsychiatry.2025.0054


Murphy, A. ADHD prescriptions on the rise: 5 study notes. Becker's Behavioral Health, March 20, 2025.


Amphetamine Misuse


Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years (JAMA Psychiatry)


The New Amphetamine Crisis (Psychology Today)


ADHD prescriptions on the rise: 5 study notes (Becker's Behavioral Health)


HEADLINES


Cannabis users under 50 are 6 times more likely to have a heart attack, new study shows


Generation Xanax: The dark side of America’s wonder drug 


New online curriculum aims at educating Appalachia on opioids


Deadliest phase of fentanyl crisis eases, as all states see recovery


New study finds alcohol-related liver disease is on the rise in young adults


Could legal weed make you sick? Here's how California tries to keep it safe


NEW PAPERS AND REPORTS


Advancing Reduction of Drug Use as an Endpoint in Addiction Treatment Trials (NIDA Director Nora Volkow/ASAM, March 24, 2025)


A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress (Cureus, March 17, 2025)


Nonfatal pediatric fentanyl exposures reported to US poison centers, 2015–2023 (American Journal of Drug and Alcohol Abuse (March14, 2025)


Find more research here

 2746 Reese Avenue, 
Evanston, IL 60201
309-242-9540
Contact Us
Facebook  Twitter  Linkedin